EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inflammatory and Organ Injury Signatures Associated with Progression to Mechanical Ventilation and Extracorporeal Membrane Oxygenation in Hospitalized Patients with COVID-19

Entzündungs- und Organschadenssignaturen bei der Progression zu mechanischer Beatmung und ECMO bei hospitalisierten Patient:innen mit COVID-19

Dandan Zhu, Daniel Diedrich, Jing Chen, Krzysztof Laudanski

Medical Sciences · 02.11.2026 · 14 (7) · 740

DOI: 10.3390/medsci14070740 ↗

Auf einen Blick

Bei 106 hospitalisierten Patient:innen mit COVID-19 waren bestimmte Entzündungs- und Organschadensmarker mit der Eskalation der Atemunterstützung bis zur ECMO assoziiert.

Fragestellung

Sind dynamische Biomarker-Veränderungen mit der Eskalation der respiratorischen Unterstützung und nachfolgendem Endorganschaden bei hospitalisierten COVID-19-Patient:innen assoziiert?

Methode

106 PCR-bestätigte COVID-19-Patient:innen; serielle Blutproben zu 24 h, 48 h, 7 Tagen und nach 28 Tagen; Vergleich nach Atemunterstützung: keine invasive Beatmung, invasive Beatmung, ECMO.

Ergebnisse

GrECMO war mit Leukozytose, erhöhtem BLC, CRP, PCT und MCP-3 sowie selektiv erhöhtem IL6 und MUC-16 assoziiert. ECMO-Progression war mit erhöhtem MCP-4, MUC-16, TIE2 und erniedrigtem PDL2/PTN verbunden.

Schlussfolgerung der Autor:innen

Der Übergang von invasiver Beatmung zu ECMO war mit Leukozytose, erhöhtem MCP-4, TIE2 und MUC-16 sowie erniedrigtem PDL2/PTN assoziiert und deutet auf eine Verschlechterung durch multisystemischen Stress hin.

Kernaussagen

  • 106 hospitalisierte Patient:innen mit PCR-bestätigter COVID-19
  • Bestimmte Entzündungsmarker waren bei ECMO erhöht
  • Keine Unterschiede bei Gerinnungs- oder Komplementmarkern

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Medical Sciences, online erschienen am 02.11.2026. Verfasst von Dandan Zhu und 3 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH NIGMS award.

Auf einen BlickAbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

ECMO is used in patients with refractory cardiopulmonary failure when conventional therapy fails; however, biomarker features associated with this clinical deterioration remain unclear. We investigated whether dynamic biomarker changes were associated with the escalation of respiratory support and subsequent end-organ injury in hospitalized patients with COVID-19.

Methods

A total of 106 hospitalized patients with PCR-confirmed COVID-19 underwent serial blood sampling within 24 h (T1), 48 h (T2), 7 days (T3), and after 28 days (T4) when available. The patients were classified by respiratory support trajectory: no invasive mechanical ventilation (GrMin), invasive mechanical ventilation (GrMV), and ECMO (GrECMO). Plasma and urine inflammatory markers were profiled, together with selected coagulation, complement, neurological, and cardiovascular injury biomarkers. Clinical characteristics, severity scores, complications, and mortality were extracted from electronic records.

Results

The patients in GrECMO were younger than those in GrMin and GrMV. The SOFA and APACHE scores were lowest in GrMin and similar between GrMV and GrECMO, while GCS was lower in GrECMO. GrECMO showed leukocytosis and elevated BLC, with increased CRP, PCT, and MCP-3 in both GrMV and GrECMO versus GrMin. IL6 and MUC-16 were selectively elevated in GrECMO, whereas PDL2 and PTN were reduced and MCP-4 increased; CAIX and TREM2 were elevated in GrMV. NCAM1 levels were numerically lower, whereas pTau181 levels were higher in GrECMO than in GrMin. Progression to ECMO was associated with leukocytosis, increased MCP-4, MUC-16, and TIE2, and reduced PDL2/PTN, while early elevations of HMGB1, CRP, PCT, and TREM2 were associated with the GrMin→MV trajectory. No differences were observed in coagulation or complement markers. Six-month mortality was higher in the MV and ECMO groups, and six-month stroke incidence was highest in the GrECMO group.

Conclusions

The transition from MV to ECMO was associated with leukocytosis, increased MCP-4, TIE2, and MUC-16, and reduced PDL2/PTN, suggesting deterioration from profound multisystem stress, beyond an acute inflammatory surge.

Förderung

  • NIH NIGMS award

Zitieren

APA

Zhu, D., Diedrich, D., Chen, J., & Laudanski, K. (2026). Inflammatory and Organ Injury Signatures Associated with Progression to Mechanical Ventilation and Extracorporeal Membrane Oxygenation in Hospitalized Patients with COVID-19. Medical Sciences, 14(7), 740. https://doi.org/10.3390/medsci14070740

Vancouver

Zhu D, Diedrich D, Chen J, Laudanski K. Inflammatory and Organ Injury Signatures Associated with Progression to Mechanical Ventilation and Extracorporeal Membrane Oxygenation in Hospitalized Patients with COVID-19. Medical Sciences. 2026;14(7):740. doi:10.3390/medsci14070740

BibTeX
@article{Zhu2026,
  author = {Zhu, Dandan and Diedrich, Daniel and Chen, Jing and Laudanski, Krzysztof},
  title = {Inflammatory and Organ Injury Signatures Associated with Progression to Mechanical Ventilation and Extracorporeal Membrane Oxygenation in Hospitalized Patients with COVID-19},
  journal = {Medical Sciences},
  year = {2026},
  volume = {14},
  number = {7},
  pages = {740},
  doi = {10.3390/medsci14070740}
}
Kostenlos starten →